Amy E. Chang
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 10
- Pancreatic and Hepatic Oncology Research 5
- Lung Cancer Research Studies 2
-
- Cancer Research and Treatments 2
- Co-authors
- Sunil R. Hingorani (4 shared papers)Vikas Kumar Goel (1 shared paper)Carlos Mario Cuevas (1 shared paper)Daniel D. Von Hoff (1 shared paper)Paolo P. Provenzano (1 shared paper)Ekram A. Gad (2 shared papers)Emily R. Larson (2 shared papers)Hailing Lu (2 shared papers)
- Journals
- Diabetes Care (3 papers)Blood (2 papers)Clinical Breast Cancer (1 paper)Otolaryngology (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Amy E. Chang
23 papers receiving 2.8k citations
Amy E. Chang's Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 1.4k
- Cancer Research 429
- Immunology 468
- Biomaterials 216
- Cell Biology 247
Countries citing papers authored by Amy E. Chang
This map shows the geographic impact of Amy E. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Chang more than expected).
Fields of papers citing papers by Amy E. Chang
This network shows the impact of papers produced by Amy E. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Chang. The network helps show where Amy E. Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2012 | 1781 |
| 2 | 2015 | 170 | |
| 3 | 2018 | 138 | |
| 4 | 2010 | 132 | |
| 5 | 2015 | 87 | |
| 6 | 2019 | 78 | |
| 7 | 2010 | 72 | |
| 8 | 2020 | 70 | |
| 9 | 2005 | 57 | |
| 10 | 2021 | 54 | |
| 11 | 2003 | 41 | |
| 12 | 1997 | 39 | |
| 13 | 2017 | 35 | |
| 14 | 2014 | 23 | |
| 15 | 2021 | 23 | |
| 16 | 2017 | 19 | |
| 17 | 2023 | 9 | |
| 18 | 2021 | 6 | |
| 19 | 2025 | 3 | |
| 20 | 2023 | 3 |
About Amy E. Chang
Amy E. Chang is a scholar working on Oncology, Biotechnology, Physical and Theoretical Chemistry, Surgery and Hematology, having authored 25 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Microfluidic and Bio-sensing Technologies (2 papers), Cancer Research and Treatments (2 papers), Diabetes and associated disorders (2 papers), Blood groups and transfusion (2 papers), Lung Cancer Research Studies (2 papers), Electrohydrodynamics and Fluid Dynamics (2 papers) and Ultrasound and Hyperthermia Applications (2 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (429 citations), Immunology (468 citations), Biomaterials (216 citations) and Cell Biology (247 citations). Amy E. Chang has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Sunil R. Hingorani, Vikas Kumar Goel, Carlos Mario Cuevas, Daniel D. Von Hoff, Paolo P. Provenzano, Ekram A. Gad, Emily R. Larson, Hailing Lu, Mary Lenora Disis and Philamer C. Calses. Their work appears in journals such as Diabetes Care, Blood, Clinical Breast Cancer, Otolaryngology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.